We investigated the relationship between SV2A PET and CSF synaptic protein changes of AD patients.<h4>Method</h4>Twenty-one participants with early AD and seven cognitively normal (CN) individuals underwent [<sup>11</sup>C]UCB-J PET. This evidence concerns the gene SV2A and Alzheimer disease.